Shukla V K, Garg S K, Kulkarni S K
Arch Int Pharmacodyn Ther. 1986 Jul;282(1):44-9.
The modulatory role of clonidine and yohimbine on the perphenazine-induced catalepsy was studied in rats. Perphenazine (5 mg/kg) produced severe catalepsy which lasted for more than 4 hr. Clonidine (50 micrograms/kg), an alpha 2-agonist, pretreatment offered protection against perphenazine-induced catalepsy. On the other hand yohimbine (5 mg/kg), an alpha 2-antagonist, pretreatment not only showed per se protective action but also potentiated the effects of clonidine against perphenazine-induced catalepsy. Yohimbine also potentiated the protective action of quipazine, a serotonin agonist. The protective effect of yohimbine is explained on the basis of its serotoninergic action.
研究了可乐定和育亨宾对大鼠奋乃静诱导的僵住症的调节作用。奋乃静(5毫克/千克)可产生持续超过4小时的严重僵住症。α2激动剂可乐定(50微克/千克)预处理可预防奋乃静诱导的僵住症。另一方面,α2拮抗剂育亨宾(5毫克/千克)预处理不仅本身具有保护作用,还增强了可乐定对奋乃静诱导僵住症的作用。育亨宾还增强了5-羟色胺激动剂喹哌嗪的保护作用。育亨宾的保护作用基于其5-羟色胺能作用来解释。